Feedback / Questions
Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith
https://www.prnewswire.com/news-releases/helixmith-announces-vm202-engensis-presentation-at-new-york-academy-of-sciences-advances-in-pain-meeting-on-may-3-2022-301536808.html
May 2, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next